corpus stringclasses 5
values | model stringclasses 3
values | configuration stringclasses 27
values | quantization stringclasses 3
values | hosted_provider stringclasses 2
values | seed int64 42 44 | repeat int64 1 3 | question_id stringclasses 50
values | question_source stringclasses 6
values | answer stringlengths 0 17.5k | files stringclasses 194
values | correct bool 2
classes | tool_calls int64 0 22 | wall_seconds float64 0 2.75k | prompt_tokens int64 0 786k | completion_tokens int64 0 109k | git_revision stringclasses 34
values | trace stringlengths 2 85.2k |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 42 | 1 | adubench_cross_000108 | xl-docbench | E/INCB/2022/1/Supp.1 | ["xl-docbench/doc_000116.md", "xl-docbench/doc_000254.md"] | true | 9 | 92.2 | 102,271 | 814 | ce027ec | [{"tool": "search", "arguments": {"query": "INCB 2022 supplement adequate availability internationally controlled drugs medical scientific purposes"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000068.md", "pages": [1, 2, 3]}, "output": "[omit... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 42 | 1 | energy:596 | vidore-energy | 2 141 | ["vidore-energy/rapport_onre_mars2022.md"] | true | 2 | 29.7 | 19,016 | 425 | ce027ec | [{"tool": "search", "arguments": {"query": "MaPrimeRénov' ventilation MWh 2020 metropolitan France"}, "output": "vidore-energy/rapport_onre_mars2022.md:10 [page 0]:\n## Tableau 7 : nombre de dossiers MaPrimeRénov' en 2020, par types de travaux et économies d'énergie conventionnelles associées\n\nEn MWh/an\n\n| Type de ... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 42 | 1 | hr:211 | vidore-hr | 50 | ["vidore-hr/labour_market_and_wage_developments_in_europe-KEBN24001ENN.md"] | true | 2 | 34.8 | 19,352 | 427 | ce027ec | [{"tool": "search", "arguments": {"query": "average hourly wage finance insurance 2021 EU"}, "output": "vidore-hr/labour_market_and_wage_developments_in_europe-KEBN24001ENN.md:210 [page 4]:\n| | | | | | | | | | | | | | | |\n\n(1) Growth rates between country specific capping incomes for each decile were ... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 42 | 1 | energy:442 | vidore-energy | Pays-Bas | ["vidore-energy/programmation_pluriannuelle_de_lenergie_20200422.md"] | true | 2 | 29.1 | 19,329 | 303 | ce027ec | [{"tool": "search", "arguments": {"query": "France B gas supply country"}, "output": "vidore-energy/listefour_janvier_2016.md:67 [page 1]:\n| Essent Trading International SA (ETISA)/RWE | 28/11/2007 19/12/2008 | | | Oui | Oui |\n| European Commodity Clearing AG (ECC) | 27/07/2008 | | | | Oui |\n| ExxonMobil Gas Ma... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 42 | 1 | industrial:85+industrial:150 | vidore-industrial | four to five inches away from the wire | ["vidore-industrial/TO_00-25-234.md"] | true | 4 | 39.2 | 26,988 | 415 | ce027ec | [{"tool": "read", "arguments": {"path": "vidore-industrial/TO_00-25-172CL-5.md"}, "output": "vidore-industrial/TO_00-25-172CL-5.md lines 1-80 of 100, pages 0-2\n1: <!-- page 0 -->\n2: # **TO 00-25-172CL-5** \n3: \n4: |AFTO|Air Force Technical Order|\n5: |---|---|\n6: |AFSC|Air Force Specialty Code|\n7: |CSO|Chief/Concu... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 42 | 1 | cuad:israel-governing-law | cuad | Marketing Agreement_ Reseller Agreement, SERVICES AGREEMENT, OUTSOURCING AGREEMENT, STRATEGIC ALLIANCE AGREEMENT | ["cuad/TodosMedicalLtd_20190328_20-F_EX-4.10_11587157_EX-4.10_Marketing Agreement_ Reseller Agreement.md", "cuad/ABILITYINC_06_15_2020-EX-4.25-SERVICES AGREEMENT.md", "cuad/NICELTD_06_26_2003-EX-4.5-OUTSOURCING AGREEMENT.md", "cuad/REWALKROBOTICSLTD_07_10_2014-EX-10.2-STRATEGIC ALLIANCE AGREEMENT.md"] | false | 7 | 119.3 | 62,729 | 1,976 | ce027ec | [{"tool": "search", "arguments": {"query": "governed by law State of Israel"}, "output": "cuad/TodosMedicalLtd_20190328_20-F_EX-4.10_11587157_EX-4.10_Marketing Agreement_ Reseller Agreement.md:54 [page 1]:\n- 15.6 Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State ... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 42 | 1 | cuad:ultragenyx-cremer-noncompete | cuad | No | ["cuad/ULTRAGENYXPHARMACEUTICALINC_12_23_2013-EX-10.9-SUPPLY AGREEMENT.md"] | true | 12 | 160.8 | 159,957 | 1,504 | ce027ec | [{"tool": "search", "arguments": {"query": "non-compete Cremer Ultragenyx"}, "output": "cuad/ULTRAGENYXPHARMACEUTICALINC_12_23_2013-EX-10.9-SUPPLY AGREEMENT.md:82 [page 2]:\n- 3) Cremer represents and warrants that all quantities of Product delivered under the Agreement were manufactured in accordance with GMP. The Pro... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 42 | 1 | finance_fr:354 | vidore-finance_fr | 97,50 % du capital | ["vidore-finance_fr/christian_dior_2023.md"] | true | 2 | 22.5 | 20,066 | 551 | ce027ec | [{"tool": "search", "arguments": {"query": "Arnault family group share capital 31 December 2023"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "vidore-finance_fr/christian_dior_2023.md", "pages": [5, 6]}, "output": "[omitted from the public variant: source lice... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 42 | 1 | cuad:adaptimmune-mdanderson-19644000 | cuad | Strategic Alliance Agreement | ["cuad/ADAPTIMMUNETHERAPEUTICSPLC_04_06_2017-EX-10.11-STRATEGIC ALLIANCE AGREEMENT.md"] | true | 5 | 72.5 | 41,676 | 883 | ce027ec | [{"tool": "search", "arguments": {"query": "$19,644,000 fund"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "search", "arguments": {"query": "19,644,000"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "cuad/ADAPTIMMUNETHERAPEUTICSPLC... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 42 | 1 | adubench_cross_000018 | xl-docbench | 2021 | ["xl-docbench/doc_000206.md", "xl-docbench/doc_000328.md"] | true | 8 | 136.5 | 57,405 | 2,162 | ce027ec | [{"tool": "search", "arguments": {"query": "Beneficial Ownership Requirements for Legal Entity Customers Overview"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000328.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 42 | 1 | adubench_single_000697 | xl-docbench | Forming the Financial Promotions and Enforcement Task Force (FPET) to intervene more assertively against financial promotions breaches | ["xl-docbench/doc_000001.md"] | true | 6 | 106.7 | 108,065 | 904 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000001.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000001.md", "pages": [3, 4, 5]}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"p... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 42 | 1 | adubench_single_000310 | xl-docbench | Twin 3-ft CMPs | ["xl-docbench/doc_000158.md"] | true | 4 | 46.7 | 30,656 | 868 | ce027ec | [{"tool": "search", "arguments": {"query": "HEC 26 Culvert Design for Aquatic Organism Passage Appendix K Sickle Creek Appendix J perched twin 36-in CMP culverts"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000158.md", "pages": [9]}, "output"... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 42 | 1 | adubench_single_000875 | xl-docbench | Morris R. Morgan | ["xl-docbench/doc_000100.md"] | true | 3 | 20.4 | 23,056 | 486 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000100.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "search", "arguments": {"query": "compliance and community affairs leadership official", "file": "xl-docbench/doc_000100.md"}, "output": "[omitted from the public variant: sourc... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 42 | 1 | adubench_single_000329 | xl-docbench | Latin | ["xl-docbench/doc_000168.md"] | false | 5 | 74.5 | 43,419 | 800 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000168.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000168.md", "start_line": 81, "line_count": 80}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", ... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 42 | 1 | adubench_single_001200 | xl-docbench | horny ring | ["xl-docbench/doc_000266.md"] | true | 6 | 94.5 | 67,425 | 1,777 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000266.md", "pages": [251, 252, 253]}, "output": "[omitted from the public variant: source licence]"}, {"tool": "search", "arguments": {"query": "TRICHODINA STEINII PLANARIA POLYCHORA"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "re... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 42 | 1 | adubench_single_000283 | xl-docbench | Equation 2 and Chart 8 | ["xl-docbench/doc_000143.md"] | false | 20 | 138 | 302,449 | 1,133 | ce027ec | [{"tool": "search", "arguments": {"query": "outlet-control headwater flowing-full concrete box culvert equations chart"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000143.md", "start_line": 1426, "line_count": 150}, "output": "[omitted from t... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 42 | 1 | adubench_single_001107 | xl-docbench | Virtual Asset Service Providers | ["xl-docbench/doc_000219.md"] | true | 6 | 66.3 | 92,702 | 802 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000219.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000219.md", "pages": [3, 4, 5]}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"p... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 42 | 1 | adubench_single_000826 | xl-docbench | Incidents directly involving biological agents | ["xl-docbench/doc_000067.md"] | true | 4 | 70.5 | 53,398 | 1,209 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000067.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000067.md", "start_line": 75, "line_count": 100}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read",... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 42 | 1 | adubench_single_000689 | xl-docbench | Further reading, page 305 | ["xl-docbench/doc_000278.md"] | true | 4 | 48.3 | 31,856 | 615 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000278.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000278.md", "pages": [5, 6]}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"page... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 42 | 1 | adubench_single_000551 | xl-docbench | economic uncertainty | ["xl-docbench/doc_000274.md"] | false | 7 | 47.6 | 82,878 | 893 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000274.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000274.md", "pages": [1, 2, 3]}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"p... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 43 | 2 | adubench_cross_000108 | xl-docbench | E/INCB/2022/1/Supp.1 | ["xl-docbench/doc_000116.md", "xl-docbench/doc_000254.md"] | true | 7 | 60.2 | 64,770 | 496 | ce027ec | [{"tool": "search", "arguments": {"query": "INCB 2022 supplement adequate availability internationally controlled drugs medical scientific purposes"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000068.md", "pages": [1, 2, 3]}, "output": "[omit... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 43 | 2 | energy:596 | vidore-energy | 2 141 | ["vidore-energy/rapport_onre_mars2022.md"] | true | 2 | 26.6 | 19,016 | 425 | ce027ec | [{"tool": "search", "arguments": {"query": "MaPrimeRénov' ventilation MWh 2020 metropolitan France"}, "output": "vidore-energy/rapport_onre_mars2022.md:10 [page 0]:\n## Tableau 7 : nombre de dossiers MaPrimeRénov' en 2020, par types de travaux et économies d'énergie conventionnelles associées\n\nEn MWh/an\n\n| Type de ... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 43 | 2 | hr:211 | vidore-hr | 50 | ["vidore-hr/labour_market_and_wage_developments_in_europe-KEBN24001ENN.md"] | true | 2 | 25.8 | 19,352 | 415 | ce027ec | [{"tool": "search", "arguments": {"query": "average hourly wage finance insurance 2021 EU"}, "output": "vidore-hr/labour_market_and_wage_developments_in_europe-KEBN24001ENN.md:210 [page 4]:\n| | | | | | | | | | | | | | | |\n\n(1) Growth rates between country specific capping incomes for each decile were ... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 43 | 2 | energy:442 | vidore-energy | Pays-Bas | ["vidore-energy/programmation_pluriannuelle_de_lenergie_20200422.md"] | true | 2 | 34.4 | 19,329 | 303 | ce027ec | [{"tool": "search", "arguments": {"query": "France B gas supply country"}, "output": "vidore-energy/listefour_janvier_2016.md:67 [page 1]:\n| Essent Trading International SA (ETISA)/RWE | 28/11/2007 19/12/2008 | | | Oui | Oui |\n| European Commodity Clearing AG (ECC) | 27/07/2008 | | | | Oui |\n| ExxonMobil Gas Ma... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 43 | 2 | industrial:85+industrial:150 | vidore-industrial | four to five inches away from the wire | ["vidore-industrial/TO_00-25-172CL-5.md", "vidore-industrial/TO_00-25-234.md"] | true | 5 | 45.3 | 36,004 | 493 | ce027ec | [{"tool": "read", "arguments": {"path": "vidore-industrial/TO_00-25-172CL-5.md"}, "output": "vidore-industrial/TO_00-25-172CL-5.md lines 1-80 of 100, pages 0-2\n1: <!-- page 0 -->\n2: # **TO 00-25-172CL-5** \n3: \n4: |AFTO|Air Force Technical Order|\n5: |---|---|\n6: |AFSC|Air Force Specialty Code|\n7: |CSO|Chief/Concu... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 43 | 2 | cuad:israel-governing-law | cuad | Marketing Agreement_ Reseller Agreement, SERVICES AGREEMENT, OUTSOURCING AGREEMENT, STRATEGIC ALLIANCE AGREEMENT | ["cuad/TodosMedicalLtd_20190328_20-F_EX-4.10_11587157_EX-4.10_Marketing Agreement_ Reseller Agreement.md", "cuad/ABILITYINC_06_15_2020-EX-4.25-SERVICES AGREEMENT.md", "cuad/NICELTD_06_26_2003-EX-4.5-OUTSOURCING AGREEMENT.md", "cuad/REWALKROBOTICSLTD_07_10_2014-EX-10.2-STRATEGIC ALLIANCE AGREEMENT.md"] | false | 7 | 128.9 | 62,729 | 1,976 | ce027ec | [{"tool": "search", "arguments": {"query": "governed by law State of Israel"}, "output": "cuad/TodosMedicalLtd_20190328_20-F_EX-4.10_11587157_EX-4.10_Marketing Agreement_ Reseller Agreement.md:54 [page 1]:\n- 15.6 Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State ... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 43 | 2 | cuad:ultragenyx-cremer-noncompete | cuad | No | ["cuad/ULTRAGENYXPHARMACEUTICALINC_12_23_2013-EX-10.9-SUPPLY AGREEMENT.md"] | true | 10 | 106 | 104,040 | 1,141 | ce027ec | [{"tool": "search", "arguments": {"query": "non-compete Cremer Ultragenyx"}, "output": "cuad/ULTRAGENYXPHARMACEUTICALINC_12_23_2013-EX-10.9-SUPPLY AGREEMENT.md:82 [page 2]:\n- 3) Cremer represents and warrants that all quantities of Product delivered under the Agreement were manufactured in accordance with GMP. The Pro... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 43 | 2 | finance_fr:354 | vidore-finance_fr | 97,50 % du capital | ["vidore-finance_fr/christian_dior_2023.md"] | true | 2 | 37.8 | 18,627 | 380 | ce027ec | [{"tool": "search", "arguments": {"query": "Arnault family capital share 31 December 2023"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "vidore-finance_fr/christian_dior_2023.md", "pages": [6]}, "output": "[omitted from the public variant: source licence]"}] |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 43 | 2 | cuad:adaptimmune-mdanderson-19644000 | cuad | STRATEGIC ALLIANCE AGREEMENT | ["cuad/ADAPTIMMUNETHERAPEUTICSPLC_04_06_2017-EX-10.11-STRATEGIC ALLIANCE AGREEMENT.md"] | true | 5 | 41.7 | 41,676 | 652 | ce027ec | [{"tool": "search", "arguments": {"query": "$19,644,000 fund"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "search", "arguments": {"query": "19,644,000"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "cuad/ADAPTIMMUNETHERAPEUTICSPLC... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 43 | 2 | adubench_cross_000018 | xl-docbench | 2021 | ["xl-docbench/doc_000206.md", "xl-docbench/doc_000328.md"] | true | 7 | 94.4 | 46,221 | 1,855 | ce027ec | [{"tool": "search", "arguments": {"query": "Beneficial Ownership Requirements for Legal Entity Customers Overview"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000328.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 43 | 2 | adubench_single_000697 | xl-docbench | Forming the Financial Promotions and Enforcement Task Force (FPET) to intervene more assertively against financial promotions breaches | ["xl-docbench/doc_000001.md"] | true | 6 | 103.1 | 101,847 | 1,396 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000001.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000001.md", "pages": [3, 4, 5, 6]}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": ... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 43 | 2 | adubench_single_000310 | xl-docbench | Twin 3-ft CMPs | ["xl-docbench/doc_000158.md"] | true | 4 | 55.5 | 30,656 | 868 | ce027ec | [{"tool": "search", "arguments": {"query": "HEC 26 Culvert Design for Aquatic Organism Passage Appendix K Sickle Creek Appendix J perched twin 36-in CMP culverts"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000158.md", "pages": [9]}, "output"... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 43 | 2 | adubench_single_000875 | xl-docbench | Morris R. Morgan | ["xl-docbench/doc_000100.md"] | true | 3 | 35.3 | 23,056 | 486 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000100.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "search", "arguments": {"query": "compliance and community affairs leadership official", "file": "xl-docbench/doc_000100.md"}, "output": "[omitted from the public variant: sourc... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 43 | 2 | adubench_single_000329 | xl-docbench | Latin | ["xl-docbench/doc_000168.md"] | false | 5 | 59.8 | 43,419 | 800 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000168.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000168.md", "start_line": 81, "line_count": 80}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", ... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 43 | 2 | adubench_single_001200 | xl-docbench | horny ring | ["xl-docbench/doc_000266.md"] | true | 4 | 89.4 | 35,504 | 1,686 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000266.md", "pages": [251, 252, 253]}, "output": "[omitted from the public variant: source licence]"}, {"tool": "search", "arguments": {"query": "TRICHODINA STEINII PLANARIA POLYCHORA"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "re... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 43 | 2 | adubench_single_000283 | xl-docbench | Equation 2 and Equation 3; Chart 8 | ["xl-docbench/doc_000143.md"] | true | 20 | 171.1 | 302,045 | 1,220 | ce027ec | [{"tool": "search", "arguments": {"query": "outlet-control headwater flowing-full concrete box culvert equations chart"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000143.md", "start_line": 1426, "line_count": 150}, "output": "[omitted from t... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 43 | 2 | adubench_single_001107 | xl-docbench | Virtual Asset Service Providers | ["xl-docbench/doc_000219.md"] | true | 7 | 73.3 | 100,743 | 790 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000219.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000219.md", "pages": [3, 4, 5]}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"p... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 43 | 2 | adubench_single_000826 | xl-docbench | Incidents directly involving biological agents | ["xl-docbench/doc_000067.md"] | true | 4 | 65 | 53,155 | 1,277 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000067.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000067.md", "start_line": 75, "line_count": 100}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read",... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 43 | 2 | adubench_single_000689 | xl-docbench | Further reading, page 305 | ["xl-docbench/doc_000278.md"] | true | 4 | 34.4 | 31,856 | 613 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000278.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000278.md", "pages": [5, 6]}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"page... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 43 | 2 | adubench_single_000551 | xl-docbench | economic uncertainty | ["xl-docbench/doc_000274.md"] | false | 9 | 83.2 | 113,761 | 1,146 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000274.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000274.md", "pages": [13, 14, 15, 16, 17, 18, 19, 20]}, "output": "[omitted from the public variant: source licence]"}, {"tool": "... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 44 | 3 | adubench_cross_000108 | xl-docbench | E/INCB/2022/1/Supp.1 | ["xl-docbench/doc_000116.md", "xl-docbench/doc_000254.md"] | true | 7 | 62.4 | 64,770 | 496 | ce027ec | [{"tool": "search", "arguments": {"query": "INCB 2022 supplement adequate availability internationally controlled drugs medical scientific purposes"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000068.md", "pages": [1, 2, 3]}, "output": "[omit... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 44 | 3 | energy:596 | vidore-energy | 2 141 MWh per year | ["vidore-energy/rapport_onre_mars2022.md"] | true | 2 | 30.1 | 19,016 | 449 | ce027ec | [{"tool": "search", "arguments": {"query": "MaPrimeRénov' ventilation MWh 2020 metropolitan France"}, "output": "vidore-energy/rapport_onre_mars2022.md:10 [page 0]:\n## Tableau 7 : nombre de dossiers MaPrimeRénov' en 2020, par types de travaux et économies d'énergie conventionnelles associées\n\nEn MWh/an\n\n| Type de ... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 44 | 3 | hr:211 | vidore-hr | 50 | ["vidore-hr/labour_market_and_wage_developments_in_europe-KEBN24001ENN.md"] | true | 2 | 34.2 | 19,352 | 427 | ce027ec | [{"tool": "search", "arguments": {"query": "average hourly wage finance insurance 2021 EU"}, "output": "vidore-hr/labour_market_and_wage_developments_in_europe-KEBN24001ENN.md:210 [page 4]:\n| | | | | | | | | | | | | | | |\n\n(1) Growth rates between country specific capping incomes for each decile were ... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 44 | 3 | energy:442 | vidore-energy | Pays-Bas | ["vidore-energy/programmation_pluriannuelle_de_lenergie_20200422.md"] | true | 2 | 23.8 | 19,329 | 303 | ce027ec | [{"tool": "search", "arguments": {"query": "France B gas supply country"}, "output": "vidore-energy/listefour_janvier_2016.md:67 [page 1]:\n| Essent Trading International SA (ETISA)/RWE | 28/11/2007 19/12/2008 | | | Oui | Oui |\n| European Commodity Clearing AG (ECC) | 27/07/2008 | | | | Oui |\n| ExxonMobil Gas Ma... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 44 | 3 | industrial:85+industrial:150 | vidore-industrial | four to five inches away from the wire | ["vidore-industrial/TO_00-25-172CL-5.md", "vidore-industrial/TO_00-25-234.md"] | true | 7 | 58.5 | 47,309 | 539 | ce027ec | [{"tool": "read", "arguments": {"path": "vidore-industrial/TO_00-25-172CL-5.md"}, "output": "vidore-industrial/TO_00-25-172CL-5.md lines 1-80 of 100, pages 0-2\n1: <!-- page 0 -->\n2: # **TO 00-25-172CL-5** \n3: \n4: |AFTO|Air Force Technical Order|\n5: |---|---|\n6: |AFSC|Air Force Specialty Code|\n7: |CSO|Chief/Concu... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 44 | 3 | cuad:israel-governing-law | cuad | Marketing Agreement_ Reseller Agreement, SERVICES AGREEMENT, OUTSOURCING AGREEMENT, STRATEGIC ALLIANCE AGREEMENT | ["cuad/TodosMedicalLtd_20190328_20-F_EX-4.10_11587157_EX-4.10_Marketing Agreement_ Reseller Agreement.md", "cuad/ABILITYINC_06_15_2020-EX-4.25-SERVICES AGREEMENT.md", "cuad/NICELTD_06_26_2003-EX-4.5-OUTSOURCING AGREEMENT.md", "cuad/REWALKROBOTICSLTD_07_10_2014-EX-10.2-STRATEGIC ALLIANCE AGREEMENT.md"] | false | 7 | 111.9 | 62,729 | 1,976 | ce027ec | [{"tool": "search", "arguments": {"query": "governed by law State of Israel"}, "output": "cuad/TodosMedicalLtd_20190328_20-F_EX-4.10_11587157_EX-4.10_Marketing Agreement_ Reseller Agreement.md:54 [page 1]:\n- 15.6 Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State ... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 44 | 3 | cuad:ultragenyx-cremer-noncompete | cuad | No | ["cuad/ULTRAGENYXPHARMACEUTICALINC_12_23_2013-EX-10.9-SUPPLY AGREEMENT.md"] | true | 10 | 91 | 104,040 | 1,141 | ce027ec | [{"tool": "search", "arguments": {"query": "non-compete Cremer Ultragenyx"}, "output": "cuad/ULTRAGENYXPHARMACEUTICALINC_12_23_2013-EX-10.9-SUPPLY AGREEMENT.md:82 [page 2]:\n- 3) Cremer represents and warrants that all quantities of Product delivered under the Agreement were manufactured in accordance with GMP. The Pro... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 44 | 3 | finance_fr:354 | vidore-finance_fr | 97,50 % du capital | ["vidore-finance_fr/christian_dior_2023.md"] | true | 2 | 27.3 | 18,627 | 380 | ce027ec | [{"tool": "search", "arguments": {"query": "Arnault family capital share 31 December 2023"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "vidore-finance_fr/christian_dior_2023.md", "pages": [6]}, "output": "[omitted from the public variant: source licence]"}] |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 44 | 3 | cuad:adaptimmune-mdanderson-19644000 | cuad | Strategic Alliance Agreement | ["cuad/ADAPTIMMUNETHERAPEUTICSPLC_04_06_2017-EX-10.11-STRATEGIC ALLIANCE AGREEMENT.md"] | true | 5 | 75.9 | 41,676 | 862 | ce027ec | [{"tool": "search", "arguments": {"query": "$19,644,000 fund"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "search", "arguments": {"query": "19,644,000"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "cuad/ADAPTIMMUNETHERAPEUTICSPLC... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 44 | 3 | adubench_cross_000018 | xl-docbench | 2021 | ["xl-docbench/doc_000206.md"] | true | 14 | 197.8 | 176,168 | 4,333 | ce027ec | [{"tool": "search", "arguments": {"query": "Beneficial Ownership Requirements for Legal Entity Customers Overview"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000328.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 44 | 3 | adubench_single_000697 | xl-docbench | Forming the Financial Promotions and Enforcement Task Force (FPET) | ["xl-docbench/doc_000001.md"] | true | 6 | 96.2 | 91,620 | 1,240 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000001.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000001.md", "pages": [3, 4, 5, 6]}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": ... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 44 | 3 | adubench_single_000310 | xl-docbench | Twin 3-ft CMPs | ["xl-docbench/doc_000158.md"] | true | 5 | 57.9 | 30,855 | 954 | ce027ec | [{"tool": "search", "arguments": {"query": "HEC 26 Culvert Design for Aquatic Organism Passage Appendix K Sickle Creek Appendix J perched twin 36-in CMP culverts"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000158.md", "pages": [9]}, "output"... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 44 | 3 | adubench_single_000875 | xl-docbench | Morris R. Morgan | ["xl-docbench/doc_000100.md"] | true | 3 | 28.5 | 23,056 | 486 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000100.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "search", "arguments": {"query": "compliance and community affairs leadership official", "file": "xl-docbench/doc_000100.md"}, "output": "[omitted from the public variant: sourc... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 44 | 3 | adubench_single_000329 | xl-docbench | Latin | ["xl-docbench/doc_000168.md"] | false | 9 | 225.2 | 122,966 | 5,410 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000168.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000168.md", "start_line": 81, "line_count": 80}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", ... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 44 | 3 | adubench_single_001200 | xl-docbench | horny ring | ["xl-docbench/doc_000266.md"] | true | 3 | 84.3 | 36,819 | 2,020 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000266.md", "pages": [251, 252, 253]}, "output": "[omitted from the public variant: source licence]"}, {"tool": "search", "arguments": {"query": "TRICHODINA STEINII PLANARIA POLYCHORA"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "re... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 44 | 3 | adubench_single_000283 | xl-docbench | Equation 2 and Equation 3, Chart 8 | ["xl-docbench/doc_000143.md"] | true | 8 | 96.3 | 155,227 | 1,158 | ce027ec | [{"tool": "search", "arguments": {"query": "outlet-control headwater flowing-full concrete box culvert equations chart"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000143.md", "start_line": 1426, "line_count": 150}, "output": "[omitted from t... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 44 | 3 | adubench_single_001107 | xl-docbench | Virtual Asset Service Providers | ["xl-docbench/doc_000219.md"] | true | 7 | 75.5 | 100,784 | 817 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000219.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000219.md", "pages": [3, 4, 5]}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"p... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 44 | 3 | adubench_single_000826 | xl-docbench | Incidents directly involving biological agents | ["xl-docbench/doc_000067.md"] | true | 4 | 63.8 | 44,225 | 1,164 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000067.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000067.md", "start_line": 75, "line_count": 100}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read",... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 44 | 3 | adubench_single_000689 | xl-docbench | Further reading, page 305 | ["xl-docbench/doc_000278.md"] | true | 4 | 34.4 | 31,856 | 613 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000278.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000278.md", "pages": [5, 6]}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"page... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_fixed_count | fp4 | Darkbloom | 44 | 3 | adubench_single_000551 | xl-docbench | economic uncertainty | ["xl-docbench/doc_000274.md"] | false | 8 | 133.5 | 254,692 | 1,464 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000274.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000274.md", "pages": [12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, ... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 42 | 1 | adubench_cross_000108 | xl-docbench | E/INCB/2022/1/Supp.1 | ["xl-docbench/doc_000254.md", "xl-docbench/doc_000116.md"] | true | 8 | 80.1 | 79,734 | 927 | ce027ec | [{"tool": "search", "arguments": {"query": "INCB 2022 supplement adequate availability internationally controlled drugs medical scientific purposes"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000068.md", "pages": [1, 2, 3]}, "output": "[omit... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 42 | 1 | energy:596 | vidore-energy | 2 141 MWh/an | ["vidore-energy/rapport_onre_mars2022.md"] | true | 2 | 32.1 | 19,166 | 422 | ce027ec | [{"tool": "search", "arguments": {"query": "MaPrimeRénov' ventilation MWh 2020 metropolitan France"}, "output": "vidore-energy/rapport_onre_mars2022.md:10 [page 0]:\n## Tableau 7 : nombre de dossiers MaPrimeRénov' en 2020, par types de travaux et économies d'énergie conventionnelles associées\n\nEn MWh/an\n\n| Type de ... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 42 | 1 | hr:211 | vidore-hr | 50 | ["vidore-hr/labour_market_and_wage_developments_in_europe-KEBN24001ENN.md"] | true | 2 | 35.2 | 19,562 | 372 | ce027ec | [{"tool": "search", "arguments": {"query": "average hourly wage finance insurance sector 2021 EU"}, "output": "vidore-hr/labour_market_and_wage_developments_in_europe-KEBN24001ENN.md:210 [page 4]:\n| | | | | | | | | | | | | | | |\n\n(1) Growth rates between country specific capping incomes for each decil... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 42 | 1 | energy:442 | vidore-energy | Pays-Bas | ["vidore-energy/programmation_pluriannuelle_de_lenergie_20200422.md"] | true | 2 | 34.5 | 19,479 | 304 | ce027ec | [{"tool": "search", "arguments": {"query": "France B gas supply country"}, "output": "vidore-energy/listefour_janvier_2016.md:67 [page 1]:\n| Essent Trading International SA (ETISA)/RWE | 28/11/2007 19/12/2008 | | | Oui | Oui |\n| European Commodity Clearing AG (ECC) | 27/07/2008 | | | | Oui |\n| ExxonMobil Gas Ma... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 42 | 1 | industrial:85+industrial:150 | vidore-industrial | four to five inches | ["vidore-industrial/TO_00-25-172CL-5.md", "vidore-industrial/TO_00-25-234.md"] | true | 5 | 48.9 | 36,304 | 594 | ce027ec | [{"tool": "read", "arguments": {"path": "vidore-industrial/TO_00-25-172CL-5.md"}, "output": "vidore-industrial/TO_00-25-172CL-5.md lines 1-80 of 100, pages 0-2\n1: <!-- page 0 -->\n2: # **TO 00-25-172CL-5** \n3: \n4: |AFTO|Air Force Technical Order|\n5: |---|---|\n6: |AFSC|Air Force Specialty Code|\n7: |CSO|Chief/Concu... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 42 | 1 | cuad:israel-governing-law | cuad | Marketing Agreement_ Reseller Agreement, SERVICES AGREEMENT, OUTSOURCING AGREEMENT, STRATEGIC ALLIANCE AGREEMENT, Manufacturing Agreement | ["cuad/TodosMedicalLtd_20190328_20-F_EX-4.10_11587157_EX-4.10_Marketing Agreement_ Reseller Agreement.md", "cuad/ABILITYINC_06_15_2020-EX-4.25-SERVICES AGREEMENT.md", "cuad/NICELTD_06_26_2003-EX-4.5-OUTSOURCING AGREEMENT.md", "cuad/REWALKROBOTICSLTD_07_10_2014-EX-10.2-STRATEGIC ALLIANCE AGREEMENT.md", "cuad/InmodeLtd_2... | false | 3 | 73.7 | 28,643 | 1,232 | ce027ec | [{"tool": "search", "arguments": {"query": "governed by law State of Israel", "passage_count": 10}, "output": "cuad/TodosMedicalLtd_20190328_20-F_EX-4.10_11587157_EX-4.10_Marketing Agreement_ Reseller Agreement.md:54 [page 1]:\n- 15.6 Governing Law. This Agreement shall be governed by and construed in accordance with t... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 42 | 1 | cuad:ultragenyx-cremer-noncompete | cuad | No, the Cremer-Ultragenyx supply agreement does not contain a non-compete clause. | ["cuad/ULTRAGENYXPHARMACEUTICALINC_12_23_2013-EX-10.9-SUPPLY AGREEMENT.md"] | true | 8 | 126.5 | 95,275 | 1,624 | ce027ec | [{"tool": "search", "arguments": {"query": "Cremer Ultragenyx supply agreement non-compete"}, "output": "cuad/ULTRAGENYXPHARMACEUTICALINC_12_23_2013-EX-10.9-SUPPLY AGREEMENT.md:53 [page 1]:\n- 2) Delivery of the Product in bulk form by Cremer shall be EXW (Incoterms 2010), unless otherwise agreed in writing by the Part... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 42 | 1 | finance_fr:354 | vidore-finance_fr | 48,60 % | ["vidore-finance_fr/lvmh_2023.md"] | false | 2 | 34.6 | 19,652 | 479 | ce027ec | [{"tool": "search", "arguments": {"query": "Christian Dior SE Arnault family group share capital 31 December 2023"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "vidore-finance_fr/lvmh_2023.md", "pages": [2, 3]}, "output": "[omitted from the public variant: sou... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 42 | 1 | cuad:adaptimmune-mdanderson-19644000 | cuad | Adaptimmune agrees to commit funding in an amount of at least nineteen million six hundred and forty four thousand Dollars US ($19,644,000) for the performance of the Studies as set out in Exhibit I during the term ("Alliance Funding"). | ["cuad/ADAPTIMMUNETHERAPEUTICSPLC_04_06_2017-EX-10.11-STRATEGIC ALLIANCE AGREEMENT.md"] | true | 11 | 160.4 | 208,490 | 1,302 | ce027ec | [{"tool": "search", "arguments": {"query": "$19,644,000 fund", "passage_count": 5}, "output": "[omitted from the public variant: source licence]"}, {"tool": "search", "arguments": {"passage_count": 10, "query": "$19,644,000"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments":... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 42 | 1 | adubench_cross_000018 | xl-docbench | 2021 | ["xl-docbench/doc_000206.md", "xl-docbench/doc_000328.md"] | true | 18 | 169.6 | 233,778 | 2,103 | ce027ec | [{"tool": "search", "arguments": {"query": "Beneficial Ownership Requirements for Legal Entity Customers Overview FFIEC BSA AML Examination Manual"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000328.md"}, "output": "[omitted from the public v... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 42 | 1 | adubench_single_000697 | xl-docbench | Using new ways to find, and act on, issues and harm faster | ["xl-docbench/doc_000001.md"] | false | 6 | 96 | 129,518 | 909 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000001.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000001.md", "pages": [3, 4, 5, 6]}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": ... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 42 | 1 | adubench_single_000310 | xl-docbench | Twin 3-ft CMPs | ["xl-docbench/doc_000158.md"] | true | 4 | 55.8 | 30,950 | 862 | ce027ec | [{"tool": "search", "arguments": {"query": "HEC 26 Culvert Design for Aquatic Organism Passage Appendix K Sickle Creek Appendix J perched twin 36-in CMP culverts"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000158.md", "pages": [9]}, "output"... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 42 | 1 | adubench_single_000875 | xl-docbench | Morris R. Morgan | ["xl-docbench/doc_000100.md"] | true | 3 | 25.8 | 23,256 | 486 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000100.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "search", "arguments": {"query": "compliance and community affairs leadership official", "file": "xl-docbench/doc_000100.md"}, "output": "[omitted from the public variant: sourc... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 42 | 1 | adubench_single_000329 | xl-docbench | Latin school drama | ["xl-docbench/doc_000168.md"] | true | 6 | 54.4 | 54,583 | 930 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000168.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000168.md", "start_line": 81, "line_count": 80}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", ... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 42 | 1 | adubench_single_001200 | xl-docbench | horny ring | ["xl-docbench/doc_000266.md"] | true | 5 | 75 | 56,685 | 1,114 | ce027ec | [{"tool": "search", "arguments": {"query": "TRICHODINA STEINII C. AND L. PLANARIA POLYCHORA O. SCHM. posterior adhesive-organ homologue Vorticella horny adhesive substance adoral cilia", "file": "xl-docbench/doc_000266.md", "passage_count": 10}, "output": "[omitted from the public variant: source licence]"}, {"tool": "... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 42 | 1 | adubench_single_000283 | xl-docbench | Equation 2 and Equation 3 are used, along with Chart 8. | ["xl-docbench/doc_000143.md"] | true | 19 | 207.9 | 370,254 | 2,046 | ce027ec | [{"tool": "search", "arguments": {"query": "outlet-control headwater flowing-full concrete box culvert equations chart", "file": "xl-docbench/doc_000143.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000143.md", "start_line": 1426, "line_cou... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 42 | 1 | adubench_single_001107 | xl-docbench | Virtual Asset Service Providers | ["xl-docbench/doc_000219.md"] | true | 7 | 75.5 | 101,293 | 790 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000219.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000219.md", "pages": [3, 4, 5]}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"p... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 42 | 1 | adubench_single_000826 | xl-docbench | Incidents directly involving biological agents | ["xl-docbench/doc_000067.md"] | true | 3 | 51.9 | 28,243 | 904 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000067.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000067.md", "pages": [5, 6, 7, 8]}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": ... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 42 | 1 | adubench_single_000689 | xl-docbench | Further reading, page 305 | ["xl-docbench/doc_000278.md"] | true | 4 | 35.1 | 32,106 | 614 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000278.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000278.md", "pages": [5, 6]}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"page... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 42 | 1 | adubench_single_000551 | xl-docbench | Economic uncertainty | ["xl-docbench/doc_000274.md"] | false | 8 | 55.6 | 57,457 | 1,069 | ce027ec | [{"tool": "search", "arguments": {"query": "Global Financial Stability Report October 2024 Executive Summary IMF Executive Board Discussion downside-risk analysis 1.2 percentage point GaR worsening"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 43 | 2 | adubench_cross_000108 | xl-docbench | E/INCB/2022/1/Supp.1 | ["xl-docbench/doc_000116.md", "xl-docbench/doc_000254.md"] | true | 12 | 140.9 | 136,708 | 1,263 | ce027ec | [{"tool": "search", "arguments": {"query": "INCB 2022 supplement adequate availability internationally controlled drugs medical scientific purposes"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000068.md", "pages": [1, 2, 3]}, "output": "[omit... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 43 | 2 | energy:596 | vidore-energy | 2 141 MWh/an | ["vidore-energy/rapport_onre_mars2022.md"] | true | 2 | 32.8 | 19,166 | 422 | ce027ec | [{"tool": "search", "arguments": {"query": "MaPrimeRénov' ventilation MWh 2020 metropolitan France"}, "output": "vidore-energy/rapport_onre_mars2022.md:10 [page 0]:\n## Tableau 7 : nombre de dossiers MaPrimeRénov' en 2020, par types de travaux et économies d'énergie conventionnelles associées\n\nEn MWh/an\n\n| Type de ... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 43 | 2 | hr:211 | vidore-hr | 50 | ["vidore-hr/labour_market_and_wage_developments_in_europe-KEBN24001ENN.md"] | true | 2 | 17 | 19,562 | 422 | ce027ec | [{"tool": "search", "arguments": {"query": "average hourly wage finance insurance sector 2021 EU"}, "output": "vidore-hr/labour_market_and_wage_developments_in_europe-KEBN24001ENN.md:210 [page 4]:\n| | | | | | | | | | | | | | | |\n\n(1) Growth rates between country specific capping incomes for each decil... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 43 | 2 | energy:442 | vidore-energy | La totalité du gaz B est importée des Pays-Bas | ["vidore-energy/programmation_pluriannuelle_de_lenergie_20200422.md"] | true | 2 | 27.2 | 19,479 | 389 | ce027ec | [{"tool": "search", "arguments": {"query": "France B gas supply country"}, "output": "vidore-energy/listefour_janvier_2016.md:67 [page 1]:\n| Essent Trading International SA (ETISA)/RWE | 28/11/2007 19/12/2008 | | | Oui | Oui |\n| European Commodity Clearing AG (ECC) | 27/07/2008 | | | | Oui |\n| ExxonMobil Gas Ma... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 43 | 2 | industrial:85+industrial:150 | vidore-industrial | four to five inches away from the wire | ["vidore-industrial/TO_00-25-172CL-5.md", "vidore-industrial/TO_00-25-234.md"] | true | 5 | 41.9 | 36,304 | 425 | ce027ec | [{"tool": "read", "arguments": {"path": "vidore-industrial/TO_00-25-172CL-5.md"}, "output": "vidore-industrial/TO_00-25-172CL-5.md lines 1-80 of 100, pages 0-2\n1: <!-- page 0 -->\n2: # **TO 00-25-172CL-5** \n3: \n4: |AFTO|Air Force Technical Order|\n5: |---|---|\n6: |AFSC|Air Force Specialty Code|\n7: |CSO|Chief/Concu... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 43 | 2 | cuad:israel-governing-law | cuad | Marketing Agreement_ Reseller Agreement, SERVICES AGREEMENT, OUTSOURCING AGREEMENT, STRATEGIC ALLIANCE AGREEMENT, Manufacturing Agreement | ["cuad/TodosMedicalLtd_20190328_20-F_EX-4.10_11587157_EX-4.10_Marketing Agreement_ Reseller Agreement.md", "cuad/ABILITYINC_06_15_2020-EX-4.25-SERVICES AGREEMENT.md", "cuad/NICELTD_06_26_2003-EX-4.5-OUTSOURCING AGREEMENT.md", "cuad/REWALKROBOTICSLTD_07_10_2014-EX-10.2-STRATEGIC ALLIANCE AGREEMENT.md", "cuad/InmodeLtd_2... | false | 3 | 80.1 | 28,658 | 1,261 | ce027ec | [{"tool": "search", "arguments": {"query": "governed by law State of Israel", "passage_count": 10}, "output": "cuad/TodosMedicalLtd_20190328_20-F_EX-4.10_11587157_EX-4.10_Marketing Agreement_ Reseller Agreement.md:54 [page 1]:\n- 15.6 Governing Law. This Agreement shall be governed by and construed in accordance with t... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 43 | 2 | cuad:ultragenyx-cremer-noncompete | cuad | No, the Cremer-Ultragenyx supply agreement does not contain a non-compete clause. It contains exclusivity provisions limited to a specific "Field" where Cremer supplies Ultragenyx exclusively and Ultragenyx purchases the Product exclusively from Cremer, but Cremer may supply the Product to other customers outside of th... | ["cuad/ULTRAGENYXPHARMACEUTICALINC_12_23_2013-EX-10.9-SUPPLY AGREEMENT.md"] | true | 7 | 96.7 | 74,345 | 1,564 | ce027ec | [{"tool": "search", "arguments": {"query": "Cremer Ultragenyx supply agreement non-compete"}, "output": "cuad/ULTRAGENYXPHARMACEUTICALINC_12_23_2013-EX-10.9-SUPPLY AGREEMENT.md:53 [page 1]:\n- 2) Delivery of the Product in bulk form by Cremer shall be EXW (Incoterms 2010), unless otherwise agreed in writing by the Part... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 43 | 2 | finance_fr:354 | vidore-finance_fr | 48,60 % | ["vidore-finance_fr/lvmh_2023.md"] | false | 2 | 28.3 | 19,652 | 479 | ce027ec | [{"tool": "search", "arguments": {"query": "Christian Dior SE Arnault family group share capital 31 December 2023"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "vidore-finance_fr/lvmh_2023.md", "pages": [2, 3]}, "output": "[omitted from the public variant: sou... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 43 | 2 | cuad:adaptimmune-mdanderson-19644000 | cuad | Adaptimmune agrees to commit funding in an amount of at least nineteen million six hundred and forty four thousand Dollars US ($19,644,000) for the performance of the Studies as set out in Exhibit I during the term ("Alliance Funding"). | ["cuad/ADAPTIMMUNETHERAPEUTICSPLC_04_06_2017-EX-10.11-STRATEGIC ALLIANCE AGREEMENT.md"] | true | 10 | 116.3 | 136,324 | 1,045 | ce027ec | [{"tool": "search", "arguments": {"query": "$19,644,000 fund", "passage_count": 5}, "output": "[omitted from the public variant: source licence]"}, {"tool": "search", "arguments": {"passage_count": 10, "query": "$19,644,000"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments":... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 43 | 2 | adubench_cross_000018 | xl-docbench | 2021 | ["xl-docbench/doc_000206.md", "xl-docbench/doc_000328.md"] | true | 19 | 208.6 | 256,291 | 2,266 | ce027ec | [{"tool": "search", "arguments": {"query": "Beneficial Ownership Requirements for Legal Entity Customers Overview FFIEC BSA AML Examination Manual"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000328.md"}, "output": "[omitted from the public v... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 43 | 2 | adubench_single_000697 | xl-docbench | Reducing non-compliant financial promotions by authorised firms | ["xl-docbench/doc_000001.md"] | false | 5 | 74.2 | 96,544 | 797 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000001.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000001.md", "pages": [3, 4, 5, 6]}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": ... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 43 | 2 | adubench_single_000310 | xl-docbench | Twin 3-ft CMPs | ["xl-docbench/doc_000158.md"] | true | 4 | 75.7 | 30,947 | 991 | ce027ec | [{"tool": "search", "arguments": {"query": "HEC 26 Culvert Design for Aquatic Organism Passage Appendix K Sickle Creek Appendix J perched twin 36-in CMP culverts"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000158.md", "pages": [9]}, "output"... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 43 | 2 | adubench_single_000875 | xl-docbench | Morris R. Morgan | ["xl-docbench/doc_000100.md"] | true | 3 | 33.4 | 23,256 | 486 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000100.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "search", "arguments": {"query": "compliance and community affairs leadership official", "file": "xl-docbench/doc_000100.md"}, "output": "[omitted from the public variant: sourc... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 43 | 2 | adubench_single_000329 | xl-docbench | Latin | ["xl-docbench/doc_000168.md"] | false | 5 | 57.4 | 43,719 | 800 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000168.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000168.md", "start_line": 81, "line_count": 80}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", ... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 43 | 2 | adubench_single_001200 | xl-docbench | horny flexible ring | ["xl-docbench/doc_000266.md"] | false | 5 | 79.1 | 46,246 | 888 | ce027ec | [{"tool": "search", "arguments": {"query": "TRICHODINA STEINII C. AND L. PLANARIA POLYCHORA O. SCHM. posterior adhesive-organ homologue Vorticella horny adhesive substance adoral cilia", "file": "xl-docbench/doc_000266.md", "passage_count": 10}, "output": "[omitted from the public variant: source licence]"}, {"tool": "... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 43 | 2 | adubench_single_000283 | xl-docbench | Equation 2 and Chart 8 | ["xl-docbench/doc_000143.md"] | false | 20 | 136.1 | 303,485 | 1,155 | ce027ec | [{"tool": "search", "arguments": {"query": "outlet-control headwater flowing-full concrete box culvert equations chart", "file": "xl-docbench/doc_000143.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000143.md", "start_line": 1426, "line_cou... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 43 | 2 | adubench_single_001107 | xl-docbench | Virtual Asset Service Providers | ["xl-docbench/doc_000219.md"] | true | 7 | 65 | 101,334 | 817 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000219.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000219.md", "pages": [3, 4, 5]}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"p... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 43 | 2 | adubench_single_000826 | xl-docbench | Incidents directly involving biological agents | ["xl-docbench/doc_000067.md"] | true | 3 | 39.5 | 28,243 | 888 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000067.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000067.md", "pages": [5, 6, 7, 8]}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": ... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 43 | 2 | adubench_single_000689 | xl-docbench | Further reading, page 305 | ["xl-docbench/doc_000278.md"] | true | 3 | 44.9 | 25,973 | 502 | ce027ec | [{"tool": "read", "arguments": {"path": "xl-docbench/doc_000278.md"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc_000278.md", "pages": [5, 6]}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"page... |
pages_validation | qwen/qwen3.5-9b | merged_bm25_excerpt_selected_count | fp4 | Darkbloom | 43 | 2 | adubench_single_000551 | xl-docbench | Economic uncertainty | ["xl-docbench/doc_000274.md"] | false | 8 | 92.5 | 71,509 | 1,096 | ce027ec | [{"tool": "search", "arguments": {"query": "Global Financial Stability Report October 2024 Executive Summary IMF Executive Board Discussion downside-risk analysis 1.2 percentage point GaR worsening"}, "output": "[omitted from the public variant: source licence]"}, {"tool": "read", "arguments": {"path": "xl-docbench/doc... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.